Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3501715018 | Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3679563011 | Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Is a | Product containing labetalol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has active ingredient | Labetalol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide and labetalol hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has active ingredient | Labetalol hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has active ingredient | Labetalol hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Labetalol hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide and labetalol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Labetalol hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Is a | Product containing only hydrochlorothiazide and labetalol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Labetalol hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Labetalol hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets